These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 10947205

  • 1. Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises.
    Wajner M, Coelho DM, Barschak AG, Araújo PR, Pires RF, Lulhier FL, Vargas CR.
    J Inherit Metab Dis; 2000 Jul; 23(5):505-12. PubMed ID: 10947205
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features.
    Chiong MA, Tan MA, Cordero CP, Fodra EG, Manliguis JS, Lopez CP, Dalmacio LM.
    Mol Genet Metab Rep; 2016 Dec; 9():46-53. PubMed ID: 27761412
    [Abstract] [Full Text] [Related]

  • 6. Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment.
    Kanakis MG, Michelakakis H, Petrou P, Koutsandrea C, Georgalas I.
    BMC Ophthalmol; 2016 Oct 03; 16(1):170. PubMed ID: 27716111
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
    Barschak AG, Sitta A, Deon M, Barden AT, Dutra-Filho CS, Wajner M, Vargas CR.
    Metab Brain Dis; 2008 Mar 03; 23(1):71-80. PubMed ID: 18026828
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diurnal changes in plasma amino acids in maple syrup urine disease.
    Schwahn B, Wendel U, Schadewaldt P, Falkenberg N, Mönch E.
    Acta Paediatr; 1998 Dec 03; 87(12):1245-6. PubMed ID: 9894823
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI.
    Pediatrics; 2002 Jun 03; 109(6):999-1008. PubMed ID: 12042535
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E, Halvorsen S.
    Am J Clin Nutr; 1980 Feb 03; 33(2):279-86. PubMed ID: 6101930
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
    Xu J, Jakher Y, Ahrens-Nicklas RC.
    Int J Mol Sci; 2020 Oct 11; 21(20):. PubMed ID: 33050626
    [Abstract] [Full Text] [Related]

  • 19. Classical maple syrup urine disease and brain development: principles of management and formula design.
    Strauss KA, Wardley B, Robinson D, Hendrickson C, Rider NL, Puffenberger EG, Shellmer D, Moser AB, Morton DH.
    Mol Genet Metab; 2010 Apr 11; 99(4):333-45. PubMed ID: 20061171
    [Abstract] [Full Text] [Related]

  • 20. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].
    Templier I, Reymond JL, Nguyen MA, Boujet C, Lantuejoul S, Beani JC, Leccia MT.
    Ann Dermatol Venereol; 2006 Apr 11; 133(4):375-9. PubMed ID: 16733455
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.